PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION

HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS

Powder Composition Based On Microparticles Embedding Nanoparticles For The Delivery Of Therapeutic/Diagnostic Compounds

PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS

Compositions and Methods for Delivering CFTR Polypeptides

THERAPEUTIC DRUG COMBINATIONS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION

Methods for Providing Rapid Relief of Motor Fluctuations in a Parkinson's Disease Patient

COMPOSITIONS, DEVICES, AND METHODS FOR INTRANASAL DELIVERY OF DRY POWDER EPINEPHRINE

NEW THERAPEUTIC APPROACH TO LUNG DISEASE

TREATMENT FOR INTERSTITIAL LUNG DISEASE

MICRONISED ANTIBODIES AND METHOD FOR THEIR OBTAINMENT

CAPSULE INHALER FOR THE ADMINISTRATION OF A PHOSPHODIESTERASE-4 INHIBITOR

CAPSULE INHALER FOR THE ADMINISTRATION OF A PHOSPHODIESTERASE-4 INHIBITOR

CAPSULE INHALER FOR THE ADMINISTRATION OF A PHOSPHODIESTERASE-4 INHIBITOR

INHALATION FORMULATION FOR TREATING IPF DISEASE AND PREPARATION METHOD THEREFOR

SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION OF SIVELESTAT OR SALT THEREOF AND PREPARATION METHOD THEREOF

TREATMENT FOR INTERSTITIAL LUNG DISEASE

TREATMENT FOR INTERSTITIAL LUNG DISEASE

Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof

PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES

METHODS FOR TREATING CANCER USING INHALED ANGIOGENESIS INHIBITOR

COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES

JAK1 SELECTIVE INHIBITORS

COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA

DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS

METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PNEUMONIA, BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, PULMONARY ARTERIAL HYPERTENSION, ADN RESPIRATORY SYNCYTIAL VIRUS

METHODS OF TREATING BRAIN DISORDERS

DRY POWDER INHALER PHARMACEUTICAL COMPOSITION OF COATED CRYSTALLINE DRY POWDER FOR INHALATION

CRYSTALLINE PHARMACEUTICAL COMPOSITION FOR INHALATION COMPRISING SUGAR AND LIPID COMPOSITE PARTICLES AND PROCESS FOR MANUFACTURE

NOVEL DOSAGE AND FORMULATION

INHALABLE COMPOSITION FOR ENHANCING ALERTNESS AND VITALITY AND DEVICE FOR SUPPLYING THE INHALABLE COMPOSITION

METHOD AND COMPOSITION FOR TREATING LUNG DISEASES

PHARMACEUTICAL COMPOSITION FOR DRY POWDER INHALATION AND PREPARATION METHOD THEREOF

Dry Powder Formulations for Messenger RNA

INHALATION FORMULATIONS CONTAINING NITRIC OXIDE RELEASING COMPOUNDS AND METHODS OF USING SAME

COMBINATIONS OF MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST

Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension

PDE5 INHIBITOR POWDER FORMULATIONS AND METHODS RELATING THERETO

FORMULATION PRODUCTION PROCESS

PHARMACEUTICAL COMPOSITIONS AND METHODS

DRY POWDER FORMULATION OF CAVEOLIN-1 PEPTIDES AND METHODS OF USE THEREOF

TOPICAL FORMULATIONS COMPRISING MONTELUKAST AND COMBINATIONS WITH MUSSEL ADHESIVE PROTEINS

STABLE ASCORBIC ACID COMPOSITIONS AND METHODS OF USING THE SAME

PHARMACEUTICAL COMPOSITION COMPRISING PLATELET-DERIVED EXTRACELLULAR VESICLES OF DIFFERENT SIZES ACTIVATED BY FREEZE-THAW CYCLES, PREPARATION PROCESS THEREOF, AND USE IN PROMOTING WOUND HEALING OF RESPIRATORY TRACT-RELATED TISSUES AND ALLEVIATING INFLAMMATION

INHALED HEDGEHOG INHIBITORS

APPLICATION OF RAMAN SPECTROSCOPY FOR THE MANUFACTURE OF INHALATION POWDERS

NEW CRYSTAL FORM OF A PDE4 INHIBITOR

Surfactant Formulations for Inhalation

METHOD AND COMPOSITION FOR TREATING LUNG DISEASES

PHARMACEUTICAL DRY POWDER INHALATION FORMULATION

Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders

Nasal Compositions and Method of Use Thereof

NINTEDANIB AND NINTEDANIB COMBINATION DRY POWDER COMPOSITIONS AND USES

METHOD FOR MANUFACTURING AN INHALABLE POWDER COMPRISING VORICONAZOLE

PROCESS FOR PREPARING (5S)-{[2-(4-CARBOXYPHENYL)ETHYL] |2-(2-{|3-CHLORO-4'-(TRIFLUOROMETHYL)BIPHENYL-4- YL]METHOXY}PHENYL)ETHYL]AMINOL-5,6,7,8-TETRAHYDROQUINOLINE-2-CARBOXYLIC ACID AND ITS CRYSTALLINE FORMS FOR USE AS PHARMACEUTICALLY ACTIVE COMPOUND

MODIFIED CAVEOLIN-1 PEPTIDES FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE

NEW PHARMACEUTICAL DEVICE FOR USE IN INTRANASAL ADMINISTRATION

Surfactant Formulations for Inhalation

USE OF ULTRARAPID ACTING INSULIN

COMPOSITIONS AND METHODS RELATED TO EXTRACELLULAR VESICLE THERAPEUTIC DELIVERY PLATFORM

INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE

ANTIFUNGAL DRUG INHALATION FORMULATIONS

Methods for Providing Rapid Relief of Motor Fluctuations in a Parkinson's Disease Patient

INHALABLE POROUS MICROSPHERE LOADED WITH RECOMBINANT HUMAN RELAXIN-2 AND PREPARATION METHOD THEREFOR

METHODS OF PREPARING CARRIER-BASED DRY POWDERS FOR INHALATION

METHOD AND COMPOSITION FOR TREATING PULMONARY FIBROSIS

ANTIFUNGAL DRY POWDERS

DOSAGE FORMS OF ACTIVE SUBSTANCES USED AGAINST VIRAL DISEASES IN DRY POWDER INHALER DEVICE FOR SYMPTOMS CAUSED BY COVID-19 AND OTHER VIRAL LUNG DISEASES

INHALATION COMPOSITE AND CARRIER BASED FORMULATION COMBINATION

FLUTICASONE FUROATE IN THE TREATMENT OF COPD

METHODS AND COMPOSITIONS FOR TREATMENT OF PULMONARY HYPERTENSION AND OTHER LUNG DISORDERS

NINTEDANIB AND NINTEDANIB COMBINATION DRY POWDER COMPOSITIONS AND USES

DRY POWDER ESKETAMINE COMPOSITION FOR USE IN THE TREATMENT OF BIPOLAR DEPRESSION BY PULMONARY ADMINISTRATION

DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY

DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY

DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY

Diketopiperazine Microparticles with Defined Specific Surface Areas

Pharmaceutical Composition for Dry Powder Inhalation and Preparation Method Thereof

PHARMACEUTICAL COMPOSITION FOR DRY POWDER INHALATION AND PREPARATION METHOD THEREOF

Pharmaceutical Composition for Dry Powder Inhalation and Preparation Method Thereof

PHARMACEUTICAL COMPOSITION FOR DRY POWDER INHALATION AND PREPARATION METHOD THEREOF

COMPOSITIONS AND METHODS OF MAKING BRITTLE-MATRIX PARTICLES THROUGH BLISTER PACK FREEZING

PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS

COMPOSITIONS AND METHODS FOR ALLEVIATING PULMONARY AILMENTS

Dry Powder Formulations of Thymic Stromal Lymphopoietin (TSLP)-Binding Antibodies and Methods of Use Thereof

DITHIOLSACCHARIDE MUCOLYTIC AGENTS AND USES THEREOF

DITHIOLSACCHARIDE MUCOLYTIC AGENTS AND USES THEREOF

DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY

TREATMENT OF CARDIOPULMONARY DISORDERS

INHALED IMATINIB FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

DRY POWDER ESKETAMINE COMPOSITION FOR USE IN THE TREATMENT OF BIPOLAR DEPRESSION BY PULMONARY ADMINISTRATION

PARP7 INHIBITORS

N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO

FORMULATION PRODUCTION PROCESS

TREPROSTINIL DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS

DRY POWDER FORMULATIONS FILLED IN AN INHALER WITH IMPROVED RESISTANCE TO HUMIDITY

PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION

NANOPARTICLE COMPOSITION FOR PULMONARY DRUG DELIVERY

FORMULATIONS OF KINASE INHIBITORS AND PROSTANOIDS

DRY POWDER FORMULATIONS FILLED IN AN INHALER WITH IMPROVED RESISTANCE TO HUMIDITY

SPRAY DRIED INHALABLE BIOTHERAPEUTICS FOR THE TREATMENT OF DISEASE

TREATMENT FOR INTERSTITIAL LUNG DISEASE

DRY POWDER FORMULATIONS OF NARROW SPECTRUM KINASE INHIBITORS

SYNTHESIS OF ESTER, CARBONATE, AND CARBAMATE-DERIVED NOVEL BIODEGRADABLE IONIZABLE LIPIDS FROM METHYL RICINOLEATE OR METHYL 12-HYDROXYSTEARATE AND ITS APPLICATIONS

PHARMACEUTICAL COMPOSITION COMPRISING TIGECYCLINE

POWDERS FOR INHALATION AND PRODUCTION PROCESS THEREOF

DRY POWDER INHALATION DELIVERY OF PHARMACEUTICALS

INHALABLE OR INGESTIBLE LACTIC ACID COMPOSITIONS FOR THE TREATMENT OF CHRONIC LUNG DISEASE

METHODS AND COMPOSITIONS FOR TREATING MUCOSAL TISSUE DISORDERS

ION CHANNEL PROSTHETIC COMPOSITIONS COMPRISING LIPID-COATED CRYSTALS OF AMPHOTERICIN B

MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE

DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS

METHODS OF TREATING BRAIN DISORDERS

METHOD AND COMPOSITION FOR TREATING OBESITY

Pharmaceutical Composition for Dry Powder Inhalation and Preparation Method Thereof

INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS

ENCAPSULATION OF LIPOPHILIC INGREDIENTS IN DISPERSIBLE SPRAY DRIED POWDERS SUITABLE FOR INHALATION

PHARMACEUTICAL FORMULATION AND A PROCESS FOR ITS PREPARATION

METHOD OF TREATING HYPOGLYCEMIA EVENTS IN DIABETES TREATMENT

Inhalable Epinephrine Formulation

MODULATORS OF ENaC EXPRESSION

USE OF A PHOSPHOLIPID AS A CRYSTALLIZATION INHIBITOR

FORMULATIONS FOR THE TREATMENT OF RESPIRATORY DISORDERS

IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF

A PROCESS FOR THE PRODUCTION OF AMCIPATRICIN DIASCORBATE AND THE USE OF THE SAME FOR THE TREATMENT OF INVASIVE FUNGAL INFECTIONS RESISTANT TO TRADITIONAL ANTIFUNGAL AGENTS

DEVICES AND METHODS FOR DELIVERING DRY POWDER MEDICAMENTS

MEDICAMENT FOR PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION

MEDICAMENT FOR PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION

REMDESIVIR COCRYSTAL, COMPOSITIONS AND METHODS THEREOF

FORMULATION OF FURIN INHIBITOR FOR INHALATION

COMPOSITIONS OF CLOFAZIMINE AND AMIKACIN FOR PULMONARY ADMINISTRATION IN THE TREATMENT OF RESPIRATORY DISEASES

LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF

DRY POWDER COMPOSITIONS OF TREPROSTINIL PRODRUGS AND METHODS OF USE THEREOF

INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS

ANTIFUNGAL DRY POWDERS

METHOD FOR GENERATING DRY POWDER SUITABLE FOR INHALATION ADMINISTRATION OF ANTIMICROBIAL PHOSPHOLIPID COMPOSITIONS

Dry powder formulation of caveolin-1 peptides and methods of use thereof

Dry powder inhaler and system for drug delivery

Inhalable Pharmaceutical Formulations

FORMULATION OF A PAN-JAK INHIBITOR

COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES

CRYSTALLINE FORMS OF N-{3-[(1S)-1-{[6-(3,4-DIMETHOXYPHENYL)PYRAZIN-2- YL]AMINO}ETHYL]PHENYL}-5-METHYLPYRIDINE-3-CARBOXAMIDE AND RELATED PRODUCTS AND METHODS

Glucocorticoid Particles and Their Use

JAK1 SELECTIVE INHIBITORS

Solid Phase Carrier for Vapor Delivery

DRY POWDER FORMULATION FOR PULMONARY DELIVERY AND METHODS OF USE

SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY

METHOD OF TREATING DIABETES TYPE 2 BY ADMINISTERING ULTRARAPID ACTING INSULIN

COMPOSITIONS AND METHODS FOR TREATING ELASTIC FIBER BREAKDOWN

KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS

INHALABLE DRY POWDER FORMULATIONS COMPRISING ANGIOGENESIS INHIBITORS

DELIVERY OF ACTIVE AGENTS

USE OF ULTRARAPID ACTING INSULIN

METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION

Formulation production process

PDE5 INHIBITOR POWDER FORMULATIONS AND METHODS RELATING THERETO

MONOVALENT METAL CATION DRY POWDERS FOR INHALATION

Treatment of cardiopulmonary disorders

Dry powder formulations of epinephrine and associated methods

STABLE ASCORBIC ACID COMPOSITIONS AND METHODS OF USING SAME

INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF

COMPOSITIONS AND METHODS TO REDUCE INFILTRATION OF PATHOGENIC AND ANTHROPOGENIC ENVIRONMENTAL FACTORS INTO THE BRAIN

DRY POWDER COMPOSITIONS OF TREPROSTINIL PRODRUGS AND METHODS OF USE THEREOF

Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound

Diketopiperazine Salts for Drug Delivery and Related Methods

INHALABLE PHARMACEUTICAL POWDER FORMULATION AND PREPARATION METHOD THEREFOR

A COMPOUND DRY POWDER INHALANT AND USE THEREOF

PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF

AN INHALABLE DRY POWDER COMPOSITION FOR PULMONARY DISEASES

DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS

INHALABLE COMPOSITION OF CLOFAZIMINE AND METHODS OF USE THEREOF

METHOD OF TREATING A PERSON AFFLICTED WITH A RESPIRATORY CONDITION AND PHARMACEUTICAL FORMULATION INCLUDING DAPSONE

LOCALIZED THERAPY OF LOWER AIRWAYS INFLAMMATORY DISORDERS WITH PROINFLAMMATORY CYTOKINE INHIBITORS

VIP and VIP Agonists, Nanoparticles, and Uses in Inflammatory T-Cell Mediated Disease

CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT

CO-FORMULATION OF POLYMYXINS FOR INHALATION

WATER-SOLUBLE CANNABINOID FORMULATION AND PREPARATION METHOD THEREFOR

Inhalable Cannabinoid Formulations

Inhalable epinephrine formulation

Method and Composition for Treating Pulmonary Fibrosis

INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF

COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST

PHARMACEUTICAL COMPOSITIONS OF NICLOSAMIDE AND A PROTEIN

METFORMIN INHALATION POWDER AEROSOL FOR TREATING IDIOPATHIC PULMONARY FIBROSIS AND PREPARATION METHOD THEREOF

INHALABLE POWDER COMPRISING VORICONAZOLE IN CRYSTALLINE FORM

AN INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE

DIHYDROERGOTAMINE DRY POWDER FORMULATIONS AND METHODS OF USE

SURFACTANT FORMULATIONS FOR INHALATION

GLUCOSIDASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF PULMONARY INFECTIONS

STABILIZATION OF CANNABINOIDS WITHIN SOLID DOSAGE FORMS

INHALABLE DRY POWDER FORMULATIONS COMPRISING ANGIOGENESIS INHIBITORS

METHOD FOR IMPROVING THE PHARMACEUTIC PROPERTIES OF MICROPARTICLES COMPRISING DIKETOPIPERAZINE AND AN ACTIVE AGENT

TOPICAL FORMULATIONS COMPRISING MONTELUKAST AND COMBINATIONS WITH MUSSEL ADHESIVE PROTEINS

SUBSTITUTED PYRIMIDINES AND METHODS OF USE

POWDER COMPOSITION BASED ON MICROPARTICLES EMBEDDING NANOPARTICLES FOR THE DELIVERY OF THERAPEUTIC/DIAGNOSTIC COMPOUNDS

NOVEL COCRYSTALS OF DEXAMETHASONE

INHALATION FORMULATION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA

Inhaled PDE-V Inhibitor Drugs

Methods of Treating or Preventing Acute Respiratory Distress Syndrome

PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES

METHODS FOR DELIVERY OF PSYCHEDELIC MEDICATIONS BY INHALATION AND SYSTEMS FOR PERFORMING THE METHODS

Rapamycin for the treatment of lymphangioleiomyomatosis

Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension

Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR3-Inhibitors

Antimicrobial and anti-inflammatory compositions

SPRAY DRIED LOW HYGROSCOPICITY ACTIVE POWDER COMPOSITIONS

METHODS FOR THE TREATMENT OF LUNG TUMORS

2-DEOXY-D-GLUCOSE FOR PREVENTION AND TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF COVID-19

Pharmaceutical device for use in intranasal administration

LOW HYGROSCOPICITY ACTIVE POWDER COMPOSITIONS

RESPIRATORY TRACT DELIVERY OF LEVODOPA AND DOPA DECARBOXYLASE INHIBITOR FOR TREATMENT OF PARKINSON'S DISEASE

INHALABLE THERAPEUTIC AGENTS

Inhalable dry powder pharmaceutical composition

FORMULATIONS INCLUDING 5-[3-(3-HYDROXYPHENOXY)AZETIDIN-1-YL]-5-METHYL-2,2-DIPHENYLHEXANAMIDE

Formulations for the delivery of autophagy stimulating trehalose

DRY POWDER FORMULATIONS FOR INHALATION

DRY FORMULATIONS OF ANTI-SARS-COV-2 VIRUS ANTIBODIES AND COMPOSITIONS AND METHODS OF USE THEREOF

PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF REMDESIVIR BY INHALATION

Inhalable formulation of fluticasone propionate and albuterol sulfate

INHALABLE RAPAMYCIN FORMULATION FOR THE TREATMENT OF PULMONARY HYPERTENSION

CLOFAZIMINE COMPOSITION AND METHOD FOR THE TREATMENT OR PROPHYLAXIS OF VIRAL INFECTIONS

POWDERED FORMULATIONS OF CROMOLYN SODIUM AND IBUPROFEN

CROMOLYN COMPOSITIONS AND METHODS THEREOF

PULMONARY FORMULATION COMPRISING CANNABINOIDS

INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS

INHALATION FORMULATIONS OF ANTIMICROBIAL COMPOUNDS

Dry powder formulations of epinephrine and associated methods

ANATABINE POWDER COMPOSITIONS

COMPOSITIONS AND METHODS FOR TREATING INFECTIONS AND NETOPATHY

INHALABLE FORMULATION

METHODS OF TREATING A CORONAVIRUS INFECTION

Dry powder formulations for inhalation

GOLF BALL-LIKE MICROPARTICLES FOR USE IN THE TREATMENT AND PREVENTION OF PULMONARY DISEASES

PARTICLE CONTAINING LIPID NANOPARTICLES AND METHOD FOR PRODUCING SAME

Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereof

Diketopiperazine Microparticles with Defined Specific Surface Areas

INHALABLE LACTOSE CONTAINING COMPOSITION

DRY POWDER INHALATION DRUG PRODUCTS EXHIBITING MOISTURE CONTROL PROPERTIES AND METHODS OF ADMINISTERING THE SAME

ANTICOAGULANT COMPOUNDS AND METHODS AND DEVICES FOR THEIR PULMONARY USE

HPMC CAPSULE WITH REDUCED POWDER RETENTION

Pulmonary Administration of ACE2 Polypeptides

Use of ultrarapid acting insulin

Stable ascorbic acid compositions and methods of using same

SYSTEM AND METHOD FOR AEROSOL PARTICLE PRODUCTION OF SUBMICRON AND NANO STRUCTURED MATERIALS

NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF

Method for the Production of Commercial Nanoparticle and Microparticle Powders

METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION

GOLD-CONTAINING AGENTS FOR THE TREATMENT OF LUNG INFECTIONS

DRIED PARTICLE INHALATION FOR DELIVERY OF CANNABIS

MONOCLONAL ANTIBODY DRY POWDERS

USE OF COMBINED INHALANT CANNABINOID THERAPY IN THE TREATMENT OF MIGRAINE

DRY POWDER INHALER

Inhalable imatinib formulations, manufacture, and uses thereof

PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION

Use of sodium dichloroisocyanurate (NaDCC) and a pharmaceutical formulation prepared therefrom

DRY LIPOSOME ADJUVANT-CONTAINING VACCINES AND RELATED METHODS THEREOF

INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF

RAPID RELIEF OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE

Peramivir Dry Powder Inhaler and Method of Preparing the Same

Methods for making compositions for pulmonary administration

Method of treating a person afflicted with COVID-19 and pharmaceutical formulation including dapsone

Compositions containing Verteporfin, Ribavirin, Gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseases

HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS

INHALABLE DRY POWDER AND AEROSOL FORMULATIONS OF JAK INHIBITORS

Dry Powder Formulations for Messenger RNA

CANNABINOID NANOMICELLE PREPARATION AND METHOD FOR PREPARING SAME

Nicotine particles

DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINE

POWDER FORMULATIONS FOR INHALATION

Dry powder formulations of epinephrine and associated methods

NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF

METHODS, COMPOSITIONS, AND VACCINES FOR TREATING A VIRUS INFECTION

DRY POWDER FORMULATIONS OF TAMIBAROTENE FOR PULMONARY AND INTRANASAL DELIVERY

Substituted pyrimidines and methods of use

METHODS FOR ADMINISTERING (R)-N-[4-(1,4,5,6-TETRAHYDRO-6-OXO-3-PYRIDAZINYL)PHENYL]ACETAMIDE

Compositions of Clofazimine, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them

Targeted therapy for treatment of chronic rhinosinusitis

Medicament for prevention or treatment of rhinovirus infection

ONCE DAILY FORMULATIONS OF TACROLIMUS

Delivery of Active Agents

Compositions and methods of making brittle-matrix particles through blister pack freezing

Methods and compositions for treatment of pulmonary hypertension and other lung disorders

COMPOSITIONS OF CANNABINOIDS FOR DELIVERY BY INHALATION

PALONOSETRON FORMULATIONS AND USES THEREOF

NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR INHALATION

Inhalable particles

RECOMBINANT INTERFERON

ELONGATE FORM MEDICAMENT CARRIER AND MEDICAMENT DISPENSER

INHALED DELIVERY OF PEPTIDE MIMICS OF CXCL10 FOR TARGETED ANTI-FIBROTIC THERAPY

TREATMENT OF LONG HAULERS SYNDROME WITH NICLOSAMIDE

PULMONARY PHARMACEUTICAL FORMULATIONS

Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)

CARRIER-BASED FORMULATIONS AND RELATED METHODS

COMPOSITIONS FOR DELIVERY OF DRUG COMBINATIONS TO TREAT LUNG DISEASE

Treprostinil derivatives and their use in pharmaceutical compositions

Application of raman spectroscopy for the manufacture of inhalation powders

ORONASAL CBD FORMULATIONS AND USES THEREOF